{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:50:01Z","timestamp":1790268601639,"version":"4.1.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This case report describes the effects of bimonthly long-acting injectable cabotegravir (CAB)\/RPV before and throughout pregnancy. CAB concentrations were comparable to those in nonpregnant individuals; RPV concentrations were 70%\u201375% lower. No virologic failure or vertical transmission occurred. Despite placental transfer, no congenital malformations were noted. Bimonthly long-acting injectable CAB\/RPV may not be suitable for pregnant women, and monitoring of exposed infants is warranted.<\/jats:p>","DOI":"10.1093\/cid\/ciae242","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T17:49:34Z","timestamp":1714844974000},"page":"1468-1471","source":"Crossref","is-referenced-by-count":29,"title":["Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV"],"prefix":"10.1093","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8674-1448","authenticated-orcid":false,"given":"Lena","family":"van der Wekken-Pas","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Medical Innovations (RIMI) , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, LMU University Hospital, Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Simon-Zuber","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, LMU University Hospital, Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Sebisch","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, LMU University Hospital, Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Wiese","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, MVZ M\u00fcnchen am Goetheplatz , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Amsterdam University Medical Center , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Medical Innovations (RIMI) , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Colbers","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Medical Innovations (RIMI) , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"key":"2024121714054270900_ciae242-B1","author":"Department of Health and Human Services (DHHS)"},{"key":"2024121714054270900_ciae242-B2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/hiv.13439","article-title":"Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials","volume":"24","author":"Patel","year":"2023","journal-title":"HIV Med"},{"key":"2024121714054270900_ciae242-B3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","article-title":"Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial","volume":"399","author":"Delany-Moretlwe","year":"2022","journal-title":"Lancet"},{"key":"2024121714054270900_ciae242-B4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/hiv.13370","article-title":"Compassionate use of long-acting cabotegravir plus rilpivirine for people living with HIV-1 in need of parenteral antiretroviral therapy","volume":"24","author":"D'Amico","year":"2023","journal-title":"HIV Med"},{"key":"2024121714054270900_ciae242-B5","author":"Committee Antiretroviral Pregnancy Registry (APR)"},{"key":"2024121714054270900_ciae242-B6","doi-asserted-by":"crossref","first-page":"ofae023","DOI":"10.1093\/ofid\/ofae023","article-title":"Guidance for the interpretation of long-acting cabotegravir and rilpivirine concentrations based on real-world therapeutic drug monitoring data and documented failures","volume":"11","author":"Thoueille","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2024121714054270900_ciae242-B7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0000000000002883","article-title":"Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis","volume":"35","author":"Cutrell","year":"2021","journal-title":"AIDS"},{"key":"2024121714054270900_ciae242-B8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/cid\/ciad020","article-title":"Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with human immunodeficiency virus 1 type 1 infection: 152-week results from ATLAS-2M, a randomized, open-label, phase 3b, noninferiority study","volume":"76","author":"Overton","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024121714054270900_ciae242-B9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/cid\/cix534","article-title":"Lowered rilpivirine exposure during the third trimester of pregnancy in human immunodeficiency virus type 1-infected women","volume":"65","author":"Schalkwijk","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2024121714054270900_ciae242-B10","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.16006","article-title":"Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy","author":"Atoyebi","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"2024121714054270900_ciae242-B11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/QAD.0000000000001755","article-title":"Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV","volume":"32","author":"Mulligan","year":"2018","journal-title":"AIDS"},{"key":"2024121714054270900_ciae242-B12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/ciaa006","article-title":"The effect of pregnancy on the pharmacokinetics of total and unbound dolutegravir and its main metabolite in women living with human immunodeficiency virus","volume":"72","author":"Bollen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024121714054270900_ciae242-B13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QAI.0000000000000318","article-title":"Raltegravir pharmacokinetics during pregnancy","volume":"67","author":"Watts","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024121714054270900_ciae242-B14","doi-asserted-by":"crossref","first-page":"e00759-20","DOI":"10.1128\/AAC.00759-20","article-title":"Effect of pregnancy on unbound raltegravir concentrations in the ANRS 160 RalFe trial","volume":"64","author":"Zheng","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2024121714054270900_ciae242-B15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1909512","article-title":"Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection","volume":"382","author":"Orkin","year":"2020","journal-title":"N Engl J Med"},{"key":"2024121714054270900_ciae242-B16","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/QAD.0000000000002637","article-title":"Placental transfer of the integrase strand inhibitors cabotegravir and bictegravir in the ex-vivo human cotyledon perfusion model","volume":"34","author":"Pencol\u00e9","year":"2020","journal-title":"AIDS"},{"key":"2024121714054270900_ciae242-B17","author":"Pharmacoloic and resistance groups (ANRS)"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae242\/58153018\/ciae242.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/6\/1468\/61214268\/ciae242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/6\/1468\/61214268\/ciae242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T15:02:52Z","timestamp":1734447772000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/79\/6\/1468\/7664635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,5,3]]},"published-print":{"date-parts":[[2024,12,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae242","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,15]]},"published":{"date-parts":[[2024,5,3]]}}}